Speech-Language Pathologists in Mine Hill, NJ Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Robin Nancy Kaufer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 195 Us Highway 46 Ste 101, Mine Hill, NJ 07803 Phone: 973-970-9412 |
 Ap Speech Language Pathology Of Nj (apslpnj) Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 195 Us Highway 46 Ste 100, Mine Hill, NJ 07803 Phone: 973-814-4066 |
Andrea Riley, MA CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 195 Us Highway 46 Ste 101, Mine Hill, NJ 07803 Phone: 973-970-9412 |
Mrs. Sandra Grace Albert Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 195 Us Highway 46 Ste 101, Mine Hill, NJ 07803 Phone: 973-970-9412 |
Brianna Scherrer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 195 Us Highway 46 Ste 101, Mine Hill, NJ 07803 Phone: 973-970-9412 |
News Archive
Boston IVF announces participant in fully enrolled egg freezing study has become pregnant
This is the first pregnancy in Massachusetts to result from egg freezing. The study was performed by Boston IVF and sponsored by an independent medical grant from EMD Serono, a biotech company with an area of focus on infertility.
Women with preeclampsia five times more likely to have end-stage kidney disease
Women with preeclampsia during pregnancy have a five-fold increased risk of end stage kidney disease (ESKD) later in life compared to women who don't develop preeclampsia during pregnancy, according to a new study published this week in PLOS Medicine by Ali Khashan of University College Cork, Ireland, and colleagues at the Karolinska Institute, Sweden and Liverpool University, UK.
Genmab and Lundbeck enter agreement to develop antibody therapeutics
Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.
New automated system may reduce opioid misuse
After more than 1,000 orthopedic procedures at a city health system, roughly 61 percent of the opioids prescribed to patients went unused, according to new research.
› Verified 9 days ago
Speech-Language Pathologists
Physical Therapists
Occupational Therapists
Chiropractors